Catalent, Inc. Announces Fourth Quarter and Fiscal Year 2017 Earnings Conference Webcast
19 Juli 2017 - 10:15PM
Business Wire
Catalent, Inc. (NYSE:CTLT) (“Catalent”), the leading global
provider of advanced delivery technologies and development
solutions for drugs, biologics, and consumer health products, today
announced that it will release financial results for the fourth
quarter and fiscal year ended June 30, 2017, after the market close
on Monday, August 28, 2017. The Company’s management will host a
webcast to discuss the results at 4:45 p.m. ET on the same day.
Catalent invites all interested parties to listen to the
webcast, which will be accessible through Catalent’s website at
http://investor.catalent.com.
A supplemental slide presentation will also be available in the
“Investors” section of Catalent’s website prior to the start of the
webcast.
The webcast replay, along with the supplemental slides, will be
available for 90 days in the “Investors” section at
www.catalent.com.
About Catalent, Inc.
Catalent, Inc. (NYSE: CTLT) is the leading global provider of
advanced delivery technologies and development solutions for drugs,
biologics and consumer health products. With over 80 years serving
the industry, Catalent has proven expertise in bringing more
customer products to market faster, enhancing product performance
and ensuring reliable clinical and commercial product supply.
Catalent employs approximately 10,000 people, including over 1,400
scientists, at more than 30 facilities across 5 continents and in
fiscal 2016 generated $1.85 billion in annual revenue. Catalent is
headquartered in Somerset, N.J. For more information, please visit
www.catalent.com.
More products. Better treatments. Reliably supplied.™
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170719006085/en/
Investor:Catalent, Inc.Thomas Castellano, (732)
537-6325investors@catalent.com
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Aug 2024 bis Sep 2024
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Sep 2023 bis Sep 2024